Clinical Trials Browser

Phase 1/2 × pexidartinib × Other hematologic neoplasm × Clear all

NCT01349049 2020-03-02

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase 1/2 Completed

90 enrolled 23 charts

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute